Bristol Myers Squibb Co. (BMY)
57.18
+0.27
(+0.47%)
USD |
NYSE |
May 29, 16:00
57.17
-0.01
(-0.02%)
After-Hours: 20:00
Bristol Myers Squibb EPS Diluted (Quarterly) : 1.308 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
| Pfizer Inc. | 0.4688 |
| AstraZeneca PLC | 0.9849 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.678B |
| Revenue (Quarterly) | 11.49B |
| Total Expenses (Quarterly) | 8.812B |
| Enterprise Value | 152.74B |
| Gross Profit Margin (Quarterly) | 66.29% |
| Profit Margin (Quarterly) | 23.31% |
| Earnings Yield | 6.23% |
| Operating Earnings Yield | 13.16% |
| Normalized Earnings Yield | 10.22 |